| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |